ERRATUM article
Front. Med.
Sec. Regulatory Science
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1611335
This article is part of the Research TopicPaediatric Drug DevelopmentView all 5 articles
Erratum: Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process
Provisionally accepted
- Frontiers Media SA, Lausanne, Switzerland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Stewart B, Lepola P, Egger GF, Ali F, Allen AJ, Croker AK, Davidson AJ, Dicks P, Faust SN, Green D, Hovinga C, Klein AV, Langham R, Nakamura H, Pioppo L, Ramroop S, Sakiyama M, Sanchez Vigil de la Villa I, Sato J, Snyder DL, Turner MA, Zaidi S, Zimmerman K and Lacaze-Masmonteil T (2025) Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process. Front. Med. 12:1539787. doi: 10.3389/fmed.2025.1539787Due to a production error, there was an error in the Conflict of Interest Statement. Instead of "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.", it should have read "DS is currently employed by company WCG Clinical. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."The publisher apologizes for this mistake.The original version of this article has been updated.
Keywords: Pediatrics, clinical trials, Regulatory Science, Research ethics review, research ethics committee, Institutional review board
Received: 14 Apr 2025; Accepted: 14 Apr 2025.
Copyright: © 2025 Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Frontiers Production Office, Frontiers Media SA, Lausanne, Switzerland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.